76 results
Page 2 of 4
8-K
EX-1.1
0615gc0 mohs4iug
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
5u5fl2 zwrdx7ksq3w0f
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
k0bg jrnfp
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
dxr6wij vpn290c3
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
CORRESP
9hozp0s
5 Feb 21
Correspondence with SEC
12:00am
8-K
i0887btyn
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
ucfeimodywip9uwamfi
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
jwkqogyvxd m8cf6l0e
26 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-1.1
9gvalcfwhnumg 9c1kbk
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
eewh wmeu
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
wmum51
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
jqqobphifj
25 Oct 19
Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock
4:03pm
CORRESP
qozqdyk
22 Jul 19
Correspondence with SEC
12:00am